|
BYSL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.062700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.394400E-01 |
| Normal-vs-Stage2 |
2.698200E-01 |
| Normal-vs-Stage3 |
3.327600E-02 |
| Normal-vs-Stage4 |
2.763800E-03 |
| Stage1-vs-Stage2 |
2.997800E-01 |
| Stage1-vs-Stage3 |
4.418000E-02 |
| Stage1-vs-Stage4 |
1.16340000000381E-06 |
| Stage2-vs-Stage3 |
9.751600E-01 |
| Stage2-vs-Stage4 |
8.673200E-01 |
| Stage3-vs-Stage4 |
7.178400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.314380E-02 |
| Normal-vs-AfricanAmerican |
7.504400E-02 |
| Normal-vs-Asian |
2.849800E-01 |
| Caucasian-vs-AfricanAmerican |
3.834000E-01 |
| Caucasian-vs-Asian |
7.277600E-01 |
| AfricanAmerican-vs-Asian |
9.413800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.131900E-02 |
| Normal-vs-Female |
7.937700E-03 |
| Male-vs-Female |
2.510200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.808400E-02 |
| Normal-vs-Extreme_Weight |
1.685810E-01 |
| Normal-vs-Obese |
4.145700E-02 |
| Normal-vs-Extreme_Obese |
4.550400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.915400E-01 |
| Normal_Weight-vs-Obese |
1.216430E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.427600E-01 |
| Extreme_Weight-vs-Obese |
1.780360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.281400E-01 |
| Obese-vs-Extreme_Obese |
1.065350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.956400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.209600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.629700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.566500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.087640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.631810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.899350E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.413000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.516760E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.137700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.480600E-01 |
| Normal-VS-Type2 PRCC |
2.488000E-02 |
| Normal-VS-KIRP CIMP |
6.462800E-03 |
| Normal-VS-Unclassified PRCC |
1.734830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.032200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.598260E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.728400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.102000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.973900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.311570E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.590570E-01 |
| Normal-vs-N1 |
1.339890E-02 |
| Normal-vs-N2 |
3.629800E-02 |
| N0-vs-N1 |
6.648300E-02 |
| N0-vs-N2 |
8.481200E-01 |
| N1-vs-N2 |
4.789700E-02 |
|
|
